|
Nru tal-Indiċi
|
Isem Kimiku
|
Nru KE
|
Nru CAS
|
Klassifikazzjoni
|
Tikkettar
|
Limiti ta’ Konċ. Speċifiċi, Fatturi-M u ATE
|
Noti
|
|
Klassi tal-Periklu u Kodiċi(jiet) tal-Kategorija
|
Kodiċi(jiet) tad-Dikjarazzjonijiet tal-Periklu
|
Pittogramma, Kodiċi(jiet) tal-Kliem Sinjal
|
Kodiċi(jiet) tad-Dikjarazzjonijiet tal-Periklu
|
Kodiċi(jiet) Supplimentari tad-Dikjarazzjonijiet tal-Periklu
|
|
“005-007-00-2
|
aċidu boriku [1]
aċidu boriku [2]
|
233-139-2 [1]
234-343-4 [2]
|
10043-35-3 [1]
11113-50-1 [2]
|
Repr. 1B
|
H360FD
|
GHS08
Dgr
|
H360FD”
|
|
|
|
|
005-008-00-8
|
triossidu tad-diboron
|
215-125-8
|
1303-86-2
|
Repr. 1B
|
H360FD
|
GHS08
Dgr
|
H360FD”
|
|
|
|
|
“005-011-00-4
|
ettaossidu tad-disodju tat-tetraboron, idrat; [1]
tetraborat tad-disodju, anidruż; [2]
aċidu ortoboriku, melħ tas-sodju [3]
dekaidrat tat-tetraborat tad-disodju [4]
pentaidrat tat-tetraborat tad-disodju [5]
|
235-541-3 [1]
215-540-4 [2]
237-560-2 [3]
215-540-4 [4]
215-540-4 [5]
|
12267-73-1 [1]
1330-43-4 [2]
13840-56-7 [3]
1303-96-4 [4]
12179-04-3 [5]
|
Repr. 1B
|
H360FD
|
GHS08
Dgr
|
H360FD”
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
“006-069-00-3
|
tijofanat-metil (ISO);
dimetil (1,2-fenilendikarbamotijoil)biskarbamat;
dimetil 4,4’-(o-fenilen)bis(3-tijoallofanat)
|
245-740-7
|
23564-05-8
|
Carc. 2
Muta. 2
Acute Tox. 4
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H351
H341
H332
H317
H400
H410
|
GHS08
GHS07
GHS09
Wng
|
H351
H341
H332
H317
H410
|
|
bil-ġbid tan-nifs: ATE = 1,7 mg/l
(trabijiet u sprejs)
M = 10
M = 10”
|
|
|
“006-076-00-1
|
mankożeb (ISO); kumpless tal-etilenebis(ditijokarbamat) (polimeriku) tal-manganiż bil-melħ taż-żingu
|
-
|
8018-01-7
|
Carc. 2
Repr. 1B
STOT RE 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H351
H360D
H373 (it-tirojde, is-sistema nervuża)
H317
H400
H410
|
GHS08
GHS07
GHS09
Dgr
|
H351
H360D
H373 (it-tirojde, is-sistema nervuża)
H317
H410
|
|
M = 10
M = 10”
|
|
|
“015-113-00-0
|
tolklofos-metil (ISO);
tijofosfat ta’ O-(2,6-dikloro-p-tolil) u O,O-dimetil
|
260-515-3
|
57018-04-9
|
Skin Sens. 1B
Aquatic Acute 1
Aquatic Chronic 1
|
H317
H400
H410
|
GHS07
GHS09
Wng
|
H317
H410
|
|
M = 1
M = 1”
|
|
|
“028-007-00-4
|
disulfur tat-trinikil;
subsulfur tan-nikil; [1]
heazlewoodite [2]
|
234-829-6 [1]
- [2]
|
12035-72-2 [1]
12035-71-1 [2]
|
Carc. 1 A
Muta. 2
Acute Tox. 3
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H350i
H341
H331
H372**
H317
H400
H410
|
GHS08
GHS06
GHS09
Dgr
|
H350i
H341
H331
H372**
H317
H410
|
|
bil-ġbid tan-nifs:
ATE = 0,92 mg/l
(trabijiet jew sprejs)”
|
|
|
“029-002-00-X
|
ossidu tad-diram;
ossidu (I) tar-ram
|
215-270-7
|
1317-39-1
|
Acute Tox. 4
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H302
H318
H400
H410
|
GHS07
GHS05
GHS09
Dgr
|
H332
H302
H318
H410
|
|
bil-ġbid tan-nifs: ATE = 3,34 mg/l (trabijiet jew sprejs)
orali: ATE = 500 mg/kg piż tal-ġisem
M = 100
M = 10”
|
|
|
“029-015-00-0
|
tijoċjanat tar-ram
|
214-183-1
|
1111-67-7
|
Aquatic Acute 1
Aquatic Chronic 1
|
H400
H410
|
GHS09
Wng
|
H410
|
EUH032
|
M = 10
M = 10”
|
|
|
“029-016-00-6
|
ossidu tar-ram(II)
|
215-269-1
|
1317-38-0
|
Aquatic Acute 1
Aquatic Chronic 1
|
H400
H410
|
GHS09
Wng
|
H410
|
|
M = 100
M = 10”
|
|
|
“029-017-00-1
|
diklorur tar-ram triidrossidu
|
215-572-9
|
1332-65-6
|
Acute Tox. 4
Acute Tox. 3
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H301
H400
H410
|
GHS06
GHS09
Dgr
|
H332
H301
H410
|
|
bil-ġbid tan-nifs: ATE = 2,83 mg/l (trabijiet jew sprejs)
orali: ATE = 299 mg/kg piż tal-ġisem
M = 10
M = 10”
|
|
|
“029-018-00-7
|
sulfat tal-eżaidrossidu tat-tetraram; [1]
idrat sulfat tal-eżaidrossidu tat-tetraram [2]
|
215-582-3 [1]
215-582-3 [2]
|
1333-22-8 [1]
12527-76-3 [2]
|
Acute Tox. 4
Aquatic Acute 1
Aquatic Chronic 1
|
H302
H400
H410
|
GHS07
GHS09
Wng
|
H302
H410
|
|
orali: ATE = 500 mg/kg piż tal-ġisem
M = 10
M = 10”
|
|
|
“029-019-01-X
|
fjokki tar-ram (miksija bl-aċidu alifatiku)
|
-
|
-
|
Acute Tox. 3
Acute Tox. 4
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H331
H302
H319
H400
H410
|
GHS06
GHS09
Dgr
|
H331
H302
H319
H410
|
|
bil-ġbid tan-nifs: ATE = 0,733 mg/l (trabijiet jew sprejs)
orali: ATE = 500 mg/kg piż tal-ġisem
M = 10
M = 10”
|
|
|
“029-020-00-8
|
idrossidu tal-karbonat tar-ram(II) tar-ram(II) (1:1)
|
235-113-6
|
12069-69-1
|
Acute Tox. 4
Acute Tox. 4
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H302
H319
H400
H410
|
GHS07
GHS09
Wng
|
H332
H302
H319
H410
|
|
bil-ġbid tan-nifs: ATE = 1,2 mg/l (trabijiet jew sprejs)
orali: ATE = 500 mg/kg piż tal-ġisem
M = 10
M = 10”
|
|
|
“029-021-00-3
|
diidrossidu tar-ram;
idrossidu tar-ram(II)
|
243-815-9
|
20427-59-2
|
Acute Tox. 2
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H330
H302
H318
H400
H410
|
GHS06
GHS05
GHS09
Dgr
|
H330
H302
H318
H410
|
|
bil-ġbid tan-nifs: ATE = 0,47 mg/l (trabijiet jew sprejs)
orali: ATE = 500 mg/kg piż tal-ġisem
M = 10
M = 10”
|
|
|
“029-022-00-9
|
taħlita ta’ bordeaux;
prodotti ta’ reazzjoni tas-sulfat tar-ram mad-diidrossidu tal-kalċju
|
-
|
8011-63-0
|
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H318
H400
H410
|
GHS07
GHS05
GHS09
Dgr
|
H332
H318
H410
|
|
bil-ġbid tan-nifs: ATE = 1,97 mg/l (trabijiet jew sprejs)
M = 10
M = 1”
|
|
|
“029-023-00-4
|
sulfat tar-ram pentaidrat
|
231-847-6
|
7758-99-8
|
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H302
H318
H400
H410
|
GHS07
GHS05
GHS09
Dgr
|
H302
H318
H410
|
|
orali: ATE = 481 mg/kg piż tal-ġisem
M = 10
M = 1”
|
|
|
“601-029-00-7
|
dipenten;
limonen [1]
(S)-p-menta-1,8-dien; l-limonen [2]
trans-1-metil-4-(1-metilvinil)ċikloeżen; [3]
(±)-1-metil-4-(1-metilvinil)ċikloeżen [4]
|
205-341-0 [1]
227-815-6 [2]
229-977-3 [3]
231-732-0 [4]
|
138-86-3 [1]
5989-54-8 [2]
6876-12-6 [3]
7705-14-8 [4]
|
Flam. Liq. 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H226
H315
H317
H400
H410
|
GHS02
GHS07
GHS09
Wng
|
H226
H315
H317
H410
|
|
|
C”
|
|
“601-096-00-2
|
(R)-p-menta-1,8-dien;
d-limonen
|
227-813-5
|
5989-27-5
|
Flam. Liq. 3
Skin Irrit. 2
Skin Sens. 1B
Asp. Tox. 1
Aquatic Acute 1
Aquatic Chronic 3
|
H226
H315
H317
H304
H400
H412
|
GHS02
GHS07
GHS08
GHS09
Dgr
|
H226
H315
H317
H304
H410
|
|
M = 1”
|
|
|
“603-024-00-5
|
1,4-diossan
|
204-661-8
|
123-91-1
|
Flam. Liq. 2
Carc. 1B
STOT SE 3
Eye Irrit. 2
|
H225
H350
H335
H319
|
GHS02
GHS08
GHS07
Dgr
|
H225
H350
H335
H319
|
EUH019
EUH066
|
|
D”
|
|
“603-066-00-4
|
7-ossa-3-ossiranilbiċiklo[4.1.0]ettan; 1,2-epossi-4-epossietilċikloeżan; diepossidu ta’ 4-vinilċikloeżen
|
203-437-7
|
106-87-6
|
Carc. 1B
Muta. 2
Repr. 1B
Acute Tox. 3
Acute Tox. 4
|
H350
H341
H360F
H331
H302
|
GHS08
GHS06
Dgr
|
H350
H341
H360F
H331
H302
|
|
bil-ġbid tan-nifs: ATE = 0,5 mg/l (trabijiet jew sprejs)
orali: ATE = 1 847 mg/kg piż tal-ġisem”
|
|
|
“603-098-00-9
|
2-fenossietanol
|
204-589-7
|
122-99-6
|
Acute Tox. 4
STOT SE 3
Eye Dam. 1
|
H302
H335
H318
|
GHS05
GHS07
Dgr
|
H302
H335
H318
|
|
orali:
ATE = 1 394 mg/kg piż tal-ġisem”
|
|
|
“606-004-00-4
|
4-metilpentan-2-ol; keton tal-metil tal-isobutil
|
203-550-1
|
108-10-1
|
Flam. Liq. 2
Carc. 2
Acute Tox. 4
STOT SE 3
Eye Irrit. 2
|
H225
H351
H332
H336
H319
|
GHS02
GHS07
GHS08
Dgr
|
H225
H351
H332
H336
H319
|
EUH066
|
bil-ġbid tan-nifs: ATE = 11-il mg/l (fwar)”
|
|
|
“607-421-00-4
|
ċipermetrina (ISO);
α-ċjano-3-fenossibenżil 3-(2,2-diklorovinil)-2,2-dimetilċiklopropankarbossilat; ċipermetrina cis/trans +/- 40/60
|
257-842-9
|
52315-07-8
|
Acute Tox. 4
Acute Tox. 4
STOT SE 3
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H302
H335
H373 (is-sistema nervuża)
H400
H410
|
GHS07
GHS08
GHS09
Wng
|
H332
H302
H335
H373 (is-sistema nervuża)
H410
|
|
orali; ATE = 500 mg/kg piż tal-ġisem
bil-ġbid tan-nifs; ATE = 3,3 mg/l (trabijiet jew sprejs)
M = 100000
M = 100000”
|
|
|
“607-424-00-0
|
triflossistrobin (ISO); (E)-metossimmino-{(E)-α-[1-(α,α,α-trifluworo-m-tolil)etilidenamminoossil]-o-tolil}aċetat tal-metil
|
-
|
141517-21-7
|
Lact.
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H362
H317
H400
H410
|
GHS07
GHS09
Wng
|
H362
H317
H410
|
|
M = 100
M = 10”
|
|
|
“607-434-00-5
|
mekoprop-P (ISO) [1] u l-imlieħ tiegħu;
aċidu (R)-2-(4-kloro-2-metilfenossi)propjoniku [1] u l-imlieħ tiegħu
|
240-539-0 [1]
|
16484-77-8 [1]
|
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H302
H318
H400
H410
|
GHS07
GHS05
GHS09
Dgr
|
H302
H318
H410
|
|
orali: ATE = 431 mg/kg piż tal-ġisem
M = 10
M = 10”
|
|
|
“608-058-00-4
|
esfenvalerat (ISO);
(S)-α-ċjano-3-fenossibenżil-(S)-2-(4-klorofenil)-3-metilbutirat
|
-
|
66230-04-4
|
Acute Tox. 3
Acute Tox. 3
STOT SE 1
STOT RE 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H331
H301
H370 (is-sistema nervuża)
H373
H317
H400
H410
|
GHS06
GHS08
GHS09
Dgr
|
H331
H301
H370 (is-sistema nervuża)
H373
H317
H410
|
|
orali; ATE = 88,5 mg/kg
piż tal-ġisem bil-ġbid tan-nifs; ATE = 0,53 mg/l (trabijiet jew sprejs)
M = 10 000
M = 10 000 ”
|
|
|
“612-067-00-9
|
3-amminometil-3,5,5-trimetilċikloeżilammina
|
220-666-8
|
2855-13-2
|
Acute Tox. 4
Skin Corr. 1B
Eye Dam. 1
Skin Sens. 1 A
|
H302
H314
H318
H317
|
GHS05
GHS07
Dgr
|
H302
H314
H317
|
|
orali: ATE = 1 030 mg/kg piż tal-ġisem
Skin Sens. 1 A; H317: C ≥ 0,001 %”
|
|
|
“612-252-00-4
|
imidakloprid (ISO);
(E)-1-(6-kloro-3-piridilmetil)-N- nitroimidażolidin-2-ilidenammina;
(2E)-1-[(6-kloropiridin-3-il)metil]-N-nitroimidażolidin-2-immina
|
428-040-8
|
138261-41-3
|
Acute Tox. 3
Aquatic Acute 1
Aquatic Chronic 1
|
H301
H400
H410
|
GHS06
GHS09
Dgr
|
H301
H410
|
|
orali: ATE = 131 mg/kg piż tal-ġisem
M = 100
M = 1 000 ”
|
|
|
“613-048-00-8
|
karbendażim (ISO); benżimidażol-2-ilkarbamat tal-metil
|
234-232-0
|
10605-21-7
|
Muta. 1B
Repr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H340
H360FD
H317
H400
H410
|
GHS07
GHS08
GHS09
Dgr
|
H340
H360FD
H317
H410
|
|
M = 10
M = 10”
|
|
|
“613-102-00-0
|
dimetomorf (ISO); (E,Z)-4-(3-(4-klorofenil)-3-(3,4-dimetossifenil)akrilojl)morfolina
|
404-200-2
|
110488-70-5
|
Repr. 1B
Aquatic Chronic 2
|
H360F
H411
|
GHS08
GHS09
Dgr
|
H360F
H411”
|
|
|
|
|
“613-111-00-X
|
1,2,4-triażol
|
206-022-9
|
288-88-0
|
Repr. 1B
Acute Tox. 4
Eye Irrit. 2
|
H360FD
H302
H319
|
GHS08
GHS07
Dgr
|
H360FD
H302
H319
|
|
orali: ATE = 1 320 mg/kg piż tal-ġisem”
|
|
|
“613-166-00-X
|
flumjoksażina (ISO);
N-(7-fluworo-3,4-diidro-3-osso-4-prop-2-inil-2H-1,4-benżossażin-6-il)ċikloeż-1-en-1,2-dikarbossimmid
|
-
|
103361-09-7
|
Repr. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H361d
H400
H410
|
GHS08
GHS09
Wng
|
H361d
H410
|
|
M = 1 000
M = 1 000 ”
|
|
|
“613-208-00-7
|
imażamoks (ISO);
aċidu (RS)-2-(4-isopropil-4-metil-5-osso-2-imidażolin-2-il)-5-metossimetilnikotiniku
|
-
|
114311-32-9
|
Repr. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H361d
H400
H410
|
GHS08
GHS09
Wng
|
H361d
H410
|
|
M = 10
M = 10”
|
|
|
“613-267-00-9
|
tijametoksam (ISO);
3-(2-kloro-tijażol-5-ilmetil)-5-metil[1,3,5]ossadiażinan-4-iliden-N-nitroammina
|
428-650-4
|
153719-23-4
|
Repr. 2
Acute Tox. 4
Aquatic Acute 1
Aquatic Chronic 1
|
H361fd
H302
H400
H410
|
GHS07
GHS08
GHS09
Wng
|
H361fd
H302
H410
|
|
orali: ATE = 780 mg/kg piż tal-ġisem
M = 10
M = 10”
|
|
|
“613-282-00-0
|
tritikonażol (ISO);
(RS)-(E)-5-(4-klorobenżiliden)-2,2-dimetil-1-(1H-1,2,4-triażol-1-metil)ċiklopentanol
|
-
|
138182-18-0
|
Repr. 2
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
|
H361f
H373
H400
H410
|
GHS08
GHS09
Wng
|
H361f
H373
H410
|
|
M = 1
M = 1”
|
|
|
“616-032-00-9
|
diflufenikan (ISO);
N-(2,4-difluworofenil)-2-[3-(trifluworometil) fenossi]-3-piridinkarbossammid; 2′,4′-difluworo-2-(α,α,α-trifluworo-m-tolilossi) nikotinanilid
|
-
|
83164-33-4
|
Aquatic Acute 1
Aquatic Chronic 1
|
H400
H410
|
GHS09
Wng
|
H410
|
|
M = 10 000
M = 1 000 ”
|
|
|
“616-106-00-0
|
fenmedifam (ISO); metil 3-(3-metilkarbanilojlossi)karbanilat
|
237-199-0
|
13684-63-4
|
Aquatic Acute 1
Aquatic Chronic 1
|
H400
H410
|
GHS09
Wng
|
H410
|
|
M = 10
M = 10”
|
|
|
“616-113-00-9
|
desmedifam (ISO);
etil 3-fenilkarbamojlossifenilkarbamat
|
237-198-5
|
13684-56-5
|
Repr. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H361d
H400
H410
|
GHS08
GHS09
Wng
|
H361d
H410
|
|
M = 10
M = 10”
|
|